Cargando…

Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy

Galactose (Gal)-deficient IgA1 (Gd-IgA1) is involved in IgA nephropathy (IgAN) pathogenesis. To reflect racial differences in clinical characteristics, we assessed disease- and race-specific heterogeneity in the O-glycosylation of the IgA1 hinge region (HR). We determined serum Gd-IgA1 levels in Cau...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohyama, Yukako, Yamaguchi, Hisateru, Ogata, Soshiro, Chiurlia, Samantha, Cox, Sharon N., Kouri, Nikoletta-Maria, Stangou, Maria J., Nakajima, Kazuki, Hayashi, Hiroki, Inaguma, Daijo, Hasegawa, Midori, Yuzawa, Yukio, Tsuboi, Naotake, Renfrow, Matthew B., Novak, Jan, Papagianni, Aikaterini A., Schena, Francesco P., Takahashi, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583103/
https://www.ncbi.nlm.nih.gov/pubmed/36277451
http://dx.doi.org/10.1016/j.isci.2022.105223
_version_ 1784812995351674880
author Ohyama, Yukako
Yamaguchi, Hisateru
Ogata, Soshiro
Chiurlia, Samantha
Cox, Sharon N.
Kouri, Nikoletta-Maria
Stangou, Maria J.
Nakajima, Kazuki
Hayashi, Hiroki
Inaguma, Daijo
Hasegawa, Midori
Yuzawa, Yukio
Tsuboi, Naotake
Renfrow, Matthew B.
Novak, Jan
Papagianni, Aikaterini A.
Schena, Francesco P.
Takahashi, Kazuo
author_facet Ohyama, Yukako
Yamaguchi, Hisateru
Ogata, Soshiro
Chiurlia, Samantha
Cox, Sharon N.
Kouri, Nikoletta-Maria
Stangou, Maria J.
Nakajima, Kazuki
Hayashi, Hiroki
Inaguma, Daijo
Hasegawa, Midori
Yuzawa, Yukio
Tsuboi, Naotake
Renfrow, Matthew B.
Novak, Jan
Papagianni, Aikaterini A.
Schena, Francesco P.
Takahashi, Kazuo
author_sort Ohyama, Yukako
collection PubMed
description Galactose (Gal)-deficient IgA1 (Gd-IgA1) is involved in IgA nephropathy (IgAN) pathogenesis. To reflect racial differences in clinical characteristics, we assessed disease- and race-specific heterogeneity in the O-glycosylation of the IgA1 hinge region (HR). We determined serum Gd-IgA1 levels in Caucasians (healthy controls [HCs], n = 31; IgAN patients, n = 63) and Asians (HCs, n = 20; IgAN patients, n = 60) and analyzed profiles of serum IgA1 HR O-glycoforms. Elevated serum Gd-IgA1 levels and reduced number of Gal residues per HR were observed in Caucasians. Reduced number of N-acetylgalactosamine (GalNAc) residues per HR and elevated relative abundance of IgA1 with three HR O-glycans were common features in IgAN patients; these features were associated with elevated blood pressure and reduced renal function. We speculate that the mechanisms underlying the reduced GalNAc content in IgA1 HR may be relevant to IgAN pathogenesis.
format Online
Article
Text
id pubmed-9583103
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95831032022-10-21 Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy Ohyama, Yukako Yamaguchi, Hisateru Ogata, Soshiro Chiurlia, Samantha Cox, Sharon N. Kouri, Nikoletta-Maria Stangou, Maria J. Nakajima, Kazuki Hayashi, Hiroki Inaguma, Daijo Hasegawa, Midori Yuzawa, Yukio Tsuboi, Naotake Renfrow, Matthew B. Novak, Jan Papagianni, Aikaterini A. Schena, Francesco P. Takahashi, Kazuo iScience Article Galactose (Gal)-deficient IgA1 (Gd-IgA1) is involved in IgA nephropathy (IgAN) pathogenesis. To reflect racial differences in clinical characteristics, we assessed disease- and race-specific heterogeneity in the O-glycosylation of the IgA1 hinge region (HR). We determined serum Gd-IgA1 levels in Caucasians (healthy controls [HCs], n = 31; IgAN patients, n = 63) and Asians (HCs, n = 20; IgAN patients, n = 60) and analyzed profiles of serum IgA1 HR O-glycoforms. Elevated serum Gd-IgA1 levels and reduced number of Gal residues per HR were observed in Caucasians. Reduced number of N-acetylgalactosamine (GalNAc) residues per HR and elevated relative abundance of IgA1 with three HR O-glycans were common features in IgAN patients; these features were associated with elevated blood pressure and reduced renal function. We speculate that the mechanisms underlying the reduced GalNAc content in IgA1 HR may be relevant to IgAN pathogenesis. Elsevier 2022-09-27 /pmc/articles/PMC9583103/ /pubmed/36277451 http://dx.doi.org/10.1016/j.isci.2022.105223 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Ohyama, Yukako
Yamaguchi, Hisateru
Ogata, Soshiro
Chiurlia, Samantha
Cox, Sharon N.
Kouri, Nikoletta-Maria
Stangou, Maria J.
Nakajima, Kazuki
Hayashi, Hiroki
Inaguma, Daijo
Hasegawa, Midori
Yuzawa, Yukio
Tsuboi, Naotake
Renfrow, Matthew B.
Novak, Jan
Papagianni, Aikaterini A.
Schena, Francesco P.
Takahashi, Kazuo
Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy
title Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy
title_full Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy
title_fullStr Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy
title_full_unstemmed Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy
title_short Racial heterogeneity of IgA1 hinge-region O-glycoforms in patients with IgA nephropathy
title_sort racial heterogeneity of iga1 hinge-region o-glycoforms in patients with iga nephropathy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583103/
https://www.ncbi.nlm.nih.gov/pubmed/36277451
http://dx.doi.org/10.1016/j.isci.2022.105223
work_keys_str_mv AT ohyamayukako racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy
AT yamaguchihisateru racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy
AT ogatasoshiro racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy
AT chiurliasamantha racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy
AT coxsharonn racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy
AT kourinikolettamaria racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy
AT stangoumariaj racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy
AT nakajimakazuki racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy
AT hayashihiroki racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy
AT inagumadaijo racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy
AT hasegawamidori racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy
AT yuzawayukio racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy
AT tsuboinaotake racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy
AT renfrowmatthewb racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy
AT novakjan racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy
AT papagianniaikaterinia racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy
AT schenafrancescop racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy
AT takahashikazuo racialheterogeneityofiga1hingeregionoglycoformsinpatientswithiganephropathy